Slow Capital Inc. Has $2.22 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Slow Capital Inc. increased its position in shares of The Clorox Company (NYSE:CLXFree Report) by 6.7% during the 4th quarter, HoldingsChannel reports. The fund owned 15,597 shares of the company’s stock after purchasing an additional 976 shares during the quarter. Slow Capital Inc.’s holdings in Clorox were worth $2,224,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in CLX. Norges Bank bought a new stake in Clorox in the fourth quarter valued at about $101,609,000. Imprint Wealth LLC raised its position in shares of Clorox by 16,986.8% during the second quarter. Imprint Wealth LLC now owns 551,392 shares of the company’s stock worth $55,139,000 after purchasing an additional 548,165 shares during the period. Qube Research & Technologies Ltd raised its position in shares of Clorox by 75.9% during the third quarter. Qube Research & Technologies Ltd now owns 1,130,481 shares of the company’s stock worth $148,161,000 after purchasing an additional 487,974 shares during the period. International Assets Investment Management LLC raised its position in shares of Clorox by 17,658.5% during the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after purchasing an additional 481,725 shares during the period. Finally, Acadian Asset Management LLC raised its position in shares of Clorox by 39.6% during the third quarter. Acadian Asset Management LLC now owns 1,467,713 shares of the company’s stock worth $192,319,000 after purchasing an additional 415,999 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CLX. Citigroup dropped their price target on Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a research report on Tuesday. JPMorgan Chase & Co. raised their price target on Clorox from $145.00 to $152.00 and gave the stock a “neutral” rating in a research report on Thursday, January 18th. Morgan Stanley reaffirmed an “equal weight” rating and set a $160.00 price target on shares of Clorox in a research report on Tuesday, March 26th. DA Davidson reissued a “neutral” rating and issued a $162.00 target price on shares of Clorox in a research report on Monday, February 5th. Finally, Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price on the stock in a research report on Tuesday, March 26th. Four equities research analysts have rated the stock with a sell rating and twelve have given a hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $148.50.

Get Our Latest Research Report on CLX

Clorox Stock Performance

Shares of NYSE CLX traded up $1.95 during midday trading on Wednesday, hitting $142.48. 1,053,248 shares of the company’s stock were exchanged, compared to its average volume of 1,126,813. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $178.21. The company’s 50 day moving average price is $150.67 and its 200 day moving average price is $141.68. The firm has a market capitalization of $17.68 billion, a PE ratio of 226.10, a price-to-earnings-growth ratio of 2.19 and a beta of 0.43.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Thursday, February 1st. The company reported $2.16 EPS for the quarter, topping the consensus estimate of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The company had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the previous year, the company posted $0.98 EPS. The firm’s revenue for the quarter was up 16.0% compared to the same quarter last year. As a group, analysts predict that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a dividend yield of 3.37%. Clorox’s dividend payout ratio is currently 761.92%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.